Review of 676 second primary tumors in patients with retinoblastoma: Association between age at onset and tumor type

Archives of Ophthalmology

Volumn 128, Issue 7, 2010, Pages 865-870

  Woo, Kyung In ^a,b   Harbour, J William ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; TRETAMINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; ADOLESCENT; ADULT; ARTICLE; BASAL CELL CARCINOMA; BENIGN TUMOR; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SUSCEPTIBILITY; CARCINOMA; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; CHONDROSARCOMA; CLINICAL ASSESSMENT; DISEASE ASSOCIATION; EMBRYONAL CARCINOMA; EWING SARCOMA; EXOCRINE GLAND; FEMALE; FIBROSARCOMA; GASTROINTESTINAL CARCINOMA; GENE MUTATION; GENETIC PREDISPOSITION; GERMLINE MICRONUCLEUS; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; INFANT; INFORMATION RETRIEVAL; IRRADIATION; LEIOMYOSARCOMA; LEUKEMIA; LIPOMA; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MALIGNANT FIBROUS HISTIOCYTOMA; MEDLINE; MELANOMA; MULTIMODALITY CANCER THERAPY; MUTATION; NEPHROBLASTOMA; NEUROBLASTOMA; NEUROECTODERM TUMOR; ONSET AGE; OSTEOSARCOMA; PINEAL BODY TUMOR; PRIORITY JOURNAL; RADIATION FIELD; RETINOBLASTOMA; RHABDOMYOSARCOMA; SARCOMA; SEBACEOUS CARCINOMA; SECOND CANCER; SQUAMOUS CELL CARCINOMA; TUMOR CLASSIFICATION; TUMOR LOCALIZATION;

ADOLESCENT; ADULT; AGE OF ONSET; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; RADIOTHERAPY; RETINAL NEOPLASMS; RETINOBLASTOMA;

EID: 77954966335     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2010.126     Document Type: Article

References (30)

1. Harbour JW. Retinoblastoma: treatment. In: Char DH, ed. Tumors of the Eye and Orbit. Philadelphia, PA: BC Decker; 2001:266-278.
2. Eng C, Li FP, Abramson DH, et al. Mortality from second tumors among long-term survivors of retinoblastoma. J Natl Cancer Inst. 1993;85(14):1121- 1128. (Pubitemid 23212278)
3. Kleinerman RA, Tucker MA, Tarone RE, et al. Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up. J Clin Oncol. 2005;23(10):2272-2279.
4. Lennox EL, Draper GJ, Sanders BM. Retinoblastoma: a study of natural history and prognosis of 268 cases. Br Med J. 1975;3(5986):731-734.
5. Fontanesi J, Parham DM, Pratt C, Meyer D. Second malignant neoplasms in children with retinoblastoma: the St. Jude Children's Research Hospital experience. Ophthalmic Genet. 1995;16(3):105-108.
6. Moll AC, Imhof SM, Bouter LM, et al. Second primary tumors in patients with hereditary retinoblastoma: a register-based follow-up study, 1945-1994. Int J Cancer. 1996;67(4):515-519.
7. Fletcher O, Easton D, Anderson K, Gilham C, Jay M, Peto J. Lifetime risks of common cancers among retinoblastoma survivors. J Natl Cancer Inst. 2004;96(5):357-363. (Pubitemid 38401013)
8. Marees T, Moll AC, Imhof SM, de Boer MR, Ringens PJ, van Leeuwen FE. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up. J Natl Cancer Inst. 2008;100(24):1771-1779.
9. Helton KJ, Fletcher BD, Kun LE, Jenkins JJ III, Pratt CB. Bone tumors other than osteosarcoma after retinoblastoma. Cancer. 1993;71(9):2847-2853. (Pubitemid 23120067)
10. Dorfmüller G, Wurtz FG, Kleinert R, Lanner G. Cerebral primitive neuro-ectodermal tumour following treatment of a unilateral retinoblastoma. Acta Neurochir (Wien). 1997;139(8):749-755.
11. Li FP, Abramson DH, Tarone RE, Kleinerman RA, Fraumeni JJ Jr, Boice JJ Jr. Hereditary retinoblastoma, lipoma, and second primary cancers. J Natl Cancer Inst. 1997;89(1):83-84.
12. Kivelä T. Trilateral retinoblastoma: a meta-analysis of hereditary retinoblastoma associated with primary ectopic intracranial retinoblastoma. J Clin Oncol. 1999;17(6):1829-1837. (Pubitemid 29269254)
13. Nishimura S, Sato T, Ueda H, Ueda K. Acute myeloblastic leukemia as a second malignancy in a patient with hereditary retinoblastoma. J Clin Oncol. 2001;19(21):4182-4183. (Pubitemid 33049540)
14. Shields CL, Meadows AT, Shields JA, Carvalho C, Smith AF. Chemoreduction for retinoblastoma may prevent intracranial neuroblastic malignancy (trilateral retinoblastoma). Arch Ophthalmol. 2001;119(9):1269-1272. (Pubitemid 32994870)
15. Harbour JW, Lai SL, Whang-Peng J, Gazdar AF, Minna JD, Kaye FJ. Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. Science. 1988;241(4863):353-357.
16. Foster MC, Kleinerman RA, Abramson DH, Seddon JM, Tarone RE, Tucker MA. Tobacco use in adult long-term survivors of retinoblastoma. Cancer Epidemiol Biomarkers Prev. 2006;15(8):1464-1468.
17. Gombos DS, Hungerford J, Abramson DH, et al. Secondary acute myelogenous leukemia in patients with retinoblastoma: is chemotherapy a factor? Ophthalmology. 2007;114(7):1378-1383.
18. Weintraub M, Revel-Vilk S, Charit M, Aker M, Pe'er J, Pèer J. Secondary acute myeloid leukemia after etoposide therapy for retinoblastoma. J Pediatr Hematol Oncol. 2007;29(9):646-648.
19. Friend SH, Bernards R, Rogelj S, et al. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature. 1986;323(6089):643-646. (Pubitemid 16008560)
20. Wadayama B, Toguchida J, Shimizu T, et al. Mutation spectrum of the retinoblastoma gene in osteosarcomas. Cancer Res. 1994;54(11):3042-3048.
21. Shew JY, Ling N, Yang XM, Fodstad O, Lee WH. Antibodies detecting abnormalities of the retinoblastoma susceptibility gene product (pp110RB) in osteosarcomas and synovial sarcomas. Oncogene Res. 1989;4(3):205-214.
22. Miller CW, Aslo A, Won A, Tan M, Lampkin B, Koeffler HP. Alterations of the p53, Rb and MDM2 genes in osteosarcoma. J Cancer Res Clin Oncol. 1996;122(9):559-565. (Pubitemid 26284557)
23. Weide R, Tiemann M, Pfluger KH, et al. Altered expression of the retinoblastoma gene product in human high grade non-Hodgkin's lymphomas. Leukemia. 1994;8(1):97-101.
24. T'Ang A, Varley JM, Chakraborty S, Murphree AL, Fung YK. Structural rearrangement of the retinoblastoma gene in human breast carcinoma. Science. 1988;242(4876):263-266.
25. Benedict WF, Xu HJ, Hu SX, Takahashi R. Role of the retinoblastoma gene in the initiation and progression of human cancer. J Clin Invest. 1990;85(4):988-993. (Pubitemid 20123737)
26. Valverde JR, Alonso J, Palacios I, Pestana A. RB1 gene mutation up-date, a metaanalysis based on 932 reported mutations available in a searchable database. BMC Genet. 2005;6:53.
27. Matsumoto H, Kobayashi O, Tamura K, Sekine I, Yamamoto M. Novel germline mutation in the RB1 gene with multifocal bone tumors following retinoblastoma. Pediatr Int. 2003;45(6):728-730.
28. Lee SY, Jeon DG, Lee JS, et al. Deletion of Rb1 gene in late osteosarcoma from survivor of unilateral retinoblastoma: a case report. J Korean Med Sci. 1996;11(1):94-98.
29. Karpeh MS, Brennan MF, Cance WG, et al. Altered patterns of retinoblastoma gene product expression in adult soft-tissue sarcomas. Br J Cancer. 1995;72(4):986-991.
30. Stampfer MR, Yaswen P. Human epithelial cell immortalization as a step in carcinogenesis. Cancer Lett. 2003;194(2):199-208.